{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:37:21Z","timestamp":1794886641834,"version":"4.9.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Sexually transmitted infections caused by <jats:italic>Chlamydia trachomatis<\/jats:italic> (CT), <jats:italic>Neisseria gonorrhoeae<\/jats:italic> (NG) and <jats:italic>Trichomonas vaginalis<\/jats:italic> (TV) remain significant global health problems. The World Health Organization (WHO) has recently conducted a multi-faceted, multi-country validation study (ProSPeRo), which included an evaluation of the Xpert CT\/NG and Xpert TV assays on the GeneXpert system (Cepheid, Sunnyvale, Ca., USA) in clinic-based settings across eight countries. To support the study, a training and quality management system was implemented and evaluated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A comprehensive training program for the study was developed. Quality control (QC) and external quality assessment (EQA) samples were provided by an accredited quality assurance provider. QC testing was conducted at 14 point-of-care testing (POCT) clinics, while EQA samples were tested by the POCT sites and a reference laboratory supporting each clinic.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>For QC testing, concordance with the expected results for CT and NG was &gt;\u200999% and rates of unsuccessful tests were\u2009&lt;\u20094%. For TV testing, concordance was similar (97%), but rates of unsuccessful tests were high (18%), particularly in the \u2018TV negative\u2019 sample. For EQA testing initially conducted in 2018, concordance was 100% for CT and NG, and 90% for TV for the reference laboratory group (which used non-GeneXpert systems). Concordance for the POCT group was also high (&gt;\u200994%) for all analytes, but this cohort (which used GeneXpert systems) exhibited a high rate of unsuccessful TV tests. All but one of these unsuccessful tests was subcategorised as \u2018invalid\u2019.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The high level of concordance for QC and EQA testing confirm that the trained operators at the POC clinical sites were competent to conduct POC testing and that the training and quality systems implemented for the ProSPeRo study were effective. The quality materials used were satisfactory for CT and NG but exhibited poor performance for TV testing on the GeneXpert system. The WHO should continue to work with industry and EQA providers to provide improved materials that are reliable, stable and cost effective for quality management, as it seeks to rollout molecular-based STI POCT in non-laboratory-based settings.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Ethics approval to conduct the ProSPeRo study was granted by the WHO Ethics Review Committee.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-024-09057-x","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:02:47Z","timestamp":1709164967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Quality control and external quality assessment for the independent clinic-based evaluation of point-of-care testing to detect Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis in eight countries"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9181-1874","authenticated-orcid":false,"given":"Mark","family":"Shephard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Andrewartha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Dimech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liza","family":"Cabuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Barbara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Cordioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Han\u00e7ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Ting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranmini","family":"Kularatne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Meli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hicham","family":"Oumzil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeska","family":"Padovese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Sandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silver","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziella","family":"Zahra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Unemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Blondeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Toskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,29]]},"reference":[{"key":"9057_CR1","unstructured":"Web Annex Key data at a glance. In: Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Accountability for the global health sector strategies 2016\u20132021: actions for impact. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO. http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/342808\/9789240030985-eng.pdf."},{"key":"9057_CR2","doi-asserted-by":"publisher","first-page":"548","DOI":"10.2471\/BLT.18.228486","volume":"97","author":"J Rowley","year":"2019","unstructured":"Rowley J, Vander Hoorn S, Korenromp E, Low N, Unemo M, Abu-Raddad LJ, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019;97:548\u2013562P. https:\/\/doi.org\/10.2471\/BLT.18.228486.","journal-title":"Bull World Health Organ"},{"key":"9057_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1370\/afm.337","volume":"3","author":"US Preventive Services Task Force","year":"2005","unstructured":"US Preventive Services Task Force. Screening for gonorrhea: recommendation statement. Ann Fam Med. 2005;3:263\u20137.","journal-title":"Ann Fam Med"},{"issue":"11","key":"9057_CR4","doi-asserted-by":"publisher","first-page":"e627","DOI":"10.1016\/S2666-5247(21)00171-3","volume":"2","author":"M Unemo","year":"2021","unstructured":"Unemo M, Lahra MM, Escher M, Eremin S, Cole MJ, Galarza P, et al. WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017-18: a retrospective observational study. Lancet Microbe. 2021;2(11):e627\u201336. https:\/\/doi.org\/10.1016\/S2666-5247(21)00171-3.","journal-title":"Lancet Microbe"},{"key":"9057_CR5","first-page":"207","volume-title":"A practical guide to global point-of-care testing","author":"M Shephard","year":"2016","unstructured":"Shephard M. A practical guide to global point-of-care testing. Melbourne: CSIRO Publishing; 2016. p. 207\u201319."},{"key":"9057_CR6","unstructured":"Point-of-care tests for sexually transmitted infections: target product profiles. Geneva: World Health Organization; 2023. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"9057_CR7","doi-asserted-by":"publisher","unstructured":"Causer LM, Guy RJ, Tabrizi SN, Whiley DM, Speers DJ, Ward J, et al. Molecular test for chlamydia and gonorrhoea used at point of care in remote primary healthcare settings: a diagnostic test evaluation. Sex Transm Infect. 2018;94:340\u20135.\u00a0https:\/\/doi.org\/10.1136\/sextrans-2017-053443.","DOI":"10.1136\/sextrans-2017-053443"},{"key":"9057_CR8","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1186\/1471-2334-13-485","volume":"13","author":"R Guy","year":"2013","unstructured":"Guy R, Natoli L, Ward J, Causer L, Hengel B, Whiley D, et al. A randomised trial of point-of-care tests for chlamydia and gonorrhoea infections in remote communities: test, treat and GO- the \u2018TTANGO\u2019 trial protocol. BMC Infect Dis. 2013;13:485. https:\/\/doi.org\/10.1186\/1471-2334-13-485.","journal-title":"BMC Infect Dis"},{"key":"9057_CR9","doi-asserted-by":"publisher","first-page":"e0145993","DOI":"10.1371\/journal.pone.0145993","volume":"10","author":"L Natoli","year":"2015","unstructured":"Natoli L, Guy RJ, Shephard M, Causer LM, Badman SG, Hengel B, et al. \u201cI do feel like a scientist at times\u201d: a qualitative study of the acceptability of molecular point-of-care testing for chlamydia and gonorrhoea to primary care professionals in a remote high STI burden setting. PLoS One. 2015;10:e0145993.","journal-title":"PLoS One"},{"key":"9057_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s43058-021-00232-8","volume":"2","author":"L Laferty","year":"2021","unstructured":"Laferty L, Smith K, Causer L, Andrewartha K, Whiley D, Badman S, et al. Scaling up sexually transmissible infections point-of-care testing in remote Aboriginal and Torres Strait islander communities: healthcare workers\u2019 perceptions of the barriers and facilitators. Implem Sci Comms. 2021;2:127. https:\/\/doi.org\/10.1186\/s43058-021-00232-8.","journal-title":"Implem Sci Comms"},{"key":"9057_CR11","first-page":"46","volume-title":"A practical guide to global point-of-care testing","author":"M Shephard","year":"2016","unstructured":"Shephard M. A practical guide to global point-of-care testing. Melbourne: CSIRO Publishing; 2016. p. 46\u201353."},{"key":"9057_CR12","first-page":"54","volume-title":"A practical guide to global point-of-care testing","author":"M Shephard","year":"2016","unstructured":"Shephard M. A practical guide to global point-of-care testing. Melbourne: CSIRO Publishing; 2016. p. 54\u201365."},{"key":"9057_CR13","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s10096-020-04143-9","volume":"40","author":"A Barrientos-Dur\u00e1n","year":"2021","unstructured":"Barrientos-Dur\u00e1n A, de Salazar A, Fuentes-L\u00f3pez A, Serrano-Conde E, Espadafor B, Chueca N, et al. Comparison between Aptima\u00ae assays (Hologic) and the CoBAS\u00ae 6800 system (Roche) for the diagnosis of sexually transmitted infections caused by Chlamydia trachomatis, Neisseria gonorrhoeae, and mycoplasma genitalium. Eur J Clin Microbiol Infect Dis. 2021;40:1337\u201342.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"9057_CR14","unstructured":"Rudd D, Ayton J, Badrick T, Griffin A, Hadlow N, Kumar A, Martin C, Sargeant A, Shephard M, Tirimacco R, Wale J, Whiley M. NPAAC Requirements for Point of Care Testing (Second Edition 2021). Australian Government Department of Health 2021.https:\/\/www1.health.gov.au\/internet\/main\/publishing.nsf\/Content\/35DE5FC4786CBB33CA257EEB007C7BF2\/$File\/DT0002469%20-%20NPAAC%20-%20Requirements%20for%20point%20of%20care%20testing%20Second%20edition%202021%20-%2020211215.pdf (Accessed 12 July 2022)."},{"key":"9057_CR15","doi-asserted-by":"crossref","unstructured":"Cabuang LM, Costa AM, Tabrizi SN, Vincini GA, Best SJ. Utility of swab samples in EQAS for CTNG and HSV-1\/2 NAT testing. In: 28th annual NRL workshop on infectious diseases. Canberra, Australia; 2011.","DOI":"10.1155\/2011\/874820"},{"key":"9057_CR16","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/S1473-3099(18)30429-","volume":"18","author":"RJ Guy","year":"2018","unstructured":"Guy RJ, Ward J, Causer LM, Natoli L, Badman SG, Tangey A, et al. Molecular point-of-care testing for chlamydia and gonorrhoea among indigenous people attending primary health services: a cross-over cluster randomised controlled trial. Lancet Infect Dis. 2018;18:1117\u201326. https:\/\/doi.org\/10.1016\/S1473-3099(18)30429-.","journal-title":"Lancet Infect Dis"},{"key":"9057_CR17","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.5858\/arpa.2020-0105-RA","volume":"144","author":"M Shephard","year":"2020","unstructured":"Shephard M, Shephard A, Matthews S, Andrewartha K. The benefits and challenges of point-of-care testing in rural and remote primary care settings in Australia. Arch Pathol Lab Med. 2020;144:1372\u201380. https:\/\/doi.org\/10.5858\/arpa.2020-0105-RA.","journal-title":"Arch Pathol Lab Med"},{"key":"9057_CR18","doi-asserted-by":"publisher","unstructured":"Spaeth B, Matthews S, Shephard M. Patient-centred point-of-care testing: A life-changing technology for remote health care. In Primary Care. Onal AE (ed), United Kingdom. IntechOpen pp1-15, doi: https:\/\/doi.org\/10.5772\/intertechopen.100375.","DOI":"10.5772\/intertechopen.100375"},{"key":"9057_CR19","first-page":"343","volume-title":"A practical guide to global point-of-care testing","author":"M Shephard","year":"2016","unstructured":"Shephard M, Causer L, Guy R. Point-of-care testing in rural, remote and indigenous settings. In: Shephard M, editor. A practical guide to global point-of-care testing. Australia: CSIRO Publishing; 2016. p. 343\u201354."},{"key":"9057_CR20","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1016\/S1473-3099(20)30859-8","volume":"21","author":"B Hengel","year":"2021","unstructured":"Hengel B, Causer L, Matthews S, Smith K, Andrewartha K, Badman S, et al. A decentralised point-of-care testing model to address inequities in the COVID-19 response. Lancet Infect Dis. 2021;21:e183\u201390. https:\/\/doi.org\/10.1016\/S1473-3099(20)30859-8.","journal-title":"Lancet Infect Dis"},{"key":"9057_CR21","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1136\/sextrans-2019-054358","volume":"96","author":"I Toskin","year":"2020","unstructured":"Toskin I, Govender V, Blondeel K, Murtagh M, Unemo M, Zemouri C, et al. Call to action for health systems integration of point-of-care testing to mitigate the transmission and burden of sexually transmitted infections. Sex Transm Infect. 2020;96:342\u20137.","journal-title":"Sex Transm Infect"},{"key":"9057_CR22","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.clinbiochem.2017.07.007","volume":"50","author":"M Shephard","year":"2017","unstructured":"Shephard M, Shephard A, McAteer B, Regnier T, Barancek K. Results from 15 years of quality surveillance for a national indigenous point-of-care testing program for diabetes. Clin Biochem. 2017;50:1159\u201363.","journal-title":"Clin Biochem"},{"issue":"11","key":"9057_CR23","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.5858\/arpa.2020-0105-RA","volume":"144","author":"S Matthews","year":"2020","unstructured":"Matthews S, Spaeth B, Duckworth L, Richards J, Prisk E, Auld M, et al. Sustained quality and service delivery in an expanding point-of-care testing network in remote Australian primary care. Arch Pathol Lab Med. 2020;144(11):1381\u201391. https:\/\/doi.org\/10.5858\/arpa.2020-0105-RA.","journal-title":"Arch Pathol Lab Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09057-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09057-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09057-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:02:55Z","timestamp":1709164975000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09057-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,29]]},"references-count":23,"journal-issue":{"issue":"S1","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["9057"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09057-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,29]]},"assertion":[{"value":"27 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval for the core protocols of the CT, NG and TV arms of the ProSPeRo study was obtained by the WHO Ethics Review Committee (ERC). Locally adapted site-specific protocols were approved by the respective local ethics committees and by ERC.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests. Some authors are current or former staff members of the World Health Organization. The authors alone are responsible for the views expressed in this publication and they do not necessarily represent the views, decisions or policies of the World Health Organization.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"203"}}